Overview
|
ONEIDA is a consortium established between Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA), Instituto Gulbenkian de Ciência (IGC) and Instituto de Medicina Molecular (iMM) to match the urgent need for effective solutions in the prevention and control of infectious diseases and antibiotic resistance.
Until 2019, more than 80 researchers will be committed in providing real time answers to specific needs of Lisbon hospitals in matters concerning infectious diseases. This will in turn provide valuable data for research advancement in the field. Coordinated by Raquel Sá-Leão and Mónica Serrano from ITQB NOVA’s unit MostMicro, ONEIDA will establish a unique core of researchers and institutions that will receive samples and information from the clinic, and then carry out genetic and protein profiling of microbial pathogens. The information gathered will allow a more informed and efficient control of infections, while supporting the scientific community working on human and animal pathogens with important data. ONEIDA will also ensure that the knowledge created by this consortium will reach all the interested stakeholders in this matter (health care institutions, policy makers, the scientific community and the general public), while training a new generation of young researchers in the field.
ONEIDA (LISBOA-01-0145-FEDER-016417) is co-funded by FEEI - "Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020" and by national funds from FCT - "Fundação para a Ciência e a Tecnologia.
ABOUT THE PARTNERS The Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA) is an academic research centre of the Universidade Nova de Lisboa. Its mission is to carry out scientific research and postgraduate teaching in chemistry, life sciences, and associated technologies, for the benefit of human health and the environment. Currently with 58 independent teams, ITQB NOVA hosts more than 460 researchers with different backgrounds and research interests. Established by the Calouste Gulbenkian Foundation, the Instituto Gulbenkian de Ciência (IGC) is an international research center devoted to biological research and to graduate training. Around 400 people work at the IGC, implementing a multidisciplinary scientific programme in an environment designed to encourage interactions and exploit synergies. The IGC also runs PhD programmes explicitly directed towards intellectual breadth and independent scientific thought, and has a dedicated outreach and public engagement in science programme. More information at www.igc.gulbenkian.pt The iMM Lisboa – Instituto de Medicina Molecular is a leading Portuguese private non-profit research institute that offers a vibrant scientific environment, aiming to nurture innovative ideias in basic, clinical and translational biomedical research.
|
